Approved Blood Products
Products that are regulated as Biologics License Applications (BLAs), New Drug Applications (NDAS), Premarket Approvals (PMAs), and 510(k)s.
Recommend0 recommendationsPublished in US National Health Agency Sources
Related Articles
An Arm and a Leg: The Prescription Drug Playbook, Part II
In response to the high price of prescription drugs, “An Arm and a Leg” asked listeners to share their strategies for getting the medicine they…
KFF Health News’ ‘What the Health?’: American Health Gets a Pink Slip
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health…
The Colorado Psychedelic Mushroom Experiment Has Arrived
BOULDER, Colo. — Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers,” where the mushrooms…
KFF Health News’ ‘What the Health?’: On Autism, It’s the Secretary’s Word vs. CDC’s
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health…
FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision
The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.
